Skip to content

Clinical trials

Completed Observational Substance-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Observational Status: Completed Clear all

183 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20024
20034
20043
20053
20067
20076
20087
20097
20107
20112
20125
20135
20149
201517
20167
20177
201812
201914
202011
202114
20226
20237
20245
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed183

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)21
Member Companies of the Opioid PMR Consortium9
Nantes University Hospital6
Indivior Inc.5
University Hospital, Montpellier5
Indiana University4
University of Colorado, Denver4
Boston Children's Hospital3
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
Johns Hopkins University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders183
Opioid-Related Disorders30
Anxiety Disorders14
HIV Infections12
Mental Disorders10
Narcotic-Related Disorders10
Cocaine-Related Disorders8
Schizophrenia8
Acquired Immunodeficiency Syndrome7
Alcoholism7

Trials

Showing 1 to 25 of 183. Each trial links to its page on Pharma Observatory.

83 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.